Neonatal severe bacterial infection impairment estimates in South Asia, sub-Saharan Africa, and Latin America for 2010. by Seale, Anna C et al.
Seale, AC; Blencowe, H; Zaidi, A; Ganatra, H; Syed, S; Engmann,
C; Newton, CR; Vergnano, S; Stoll, BJ; Cousens, SN; Lawn, JE
(2013) Neonatal severe bacterial infection impairment estimates in
South Asia, sub-Saharan Africa, and Latin America for 2010. Pe-
diatric research, 74 Suppl 1. pp. 73-85. ISSN 0031-3998 DOI:
10.1038/pr.2013.207
Downloaded from: http://researchonline.lshtm.ac.uk/1440272/
DOI: 10.1038/pr.2013.207
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by-nc-sa/2.5/
ArticlesPopulation Studynature publishing group
Background: Survivors of neonatal infections are at risk of 
neurodevelopmental impairment (NDI), a burden not previ-
ously systematically quantified  and yet important for program 
priority setting. Systematic reviews and meta-analyses were 
undertaken and applied in a three-step compartmental model 
to estimate NDI cases after severe neonatal bacterial infection 
in South Asia, sub-Saharan Africa, and Latin America in neo-
nates of >32 wk gestation (or >1,500 g).
Methods: We estimated cases of sepsis, meningitis, pneu-
monia, or no severe bacterial infection from among estimated 
cases of possible severe bacterial infection ((pSBI) step 1). We 
applied respective case fatality risks ((CFRs) step 2) and the NDI 
risk among survivors (step 3). For neonatal tetanus, incidence 
estimates were based on the estimated deaths, CFRs, and risk 
of subsequent NDI.
results: For 2010, we estimated 1.7 million (uncertainty 
range: 1.1–2.4 million) cases of neonatal sepsis, 200,000 
(21,000–350,000) cases of meningitis, 510,000 cases (150,000–
930,000) of pneumonia, and 79,000 cases (70,000–930,000) of 
tetanus in neonates >32 wk gestation (or >1,500 g). Among the 
survivors, we estimated moderate to severe NDI after neonatal 
meningitis in 23% (95% confidence interval: 19–26%) of survi-
vors, 18,000 (2,700–35,000) cases, and after neonatal tetanus in 
16% (6–27%), 4,700 cases (1,700–8,900).
conclusion: Data are lacking for impairment after neona-
tal sepsis and pneumonia, especially among those of >32 wk 
gestation. Improved recognition and treatment of pSBI will 
reduce neonatal mortality. Lack of follow-up data for survivors 
of severe bacterial infections, particularly sepsis, was striking. 
Given the high incidence of sepsis, even minor NDI would be 
of major public health importance. Prevention of neonatal 
infection, improved case management, and support for chil-
dren with NDI are all important strategies, currently receiving 
limited policy attention.
in 2011, neonatal deaths accounted for 34% (1.1 million) of all child deaths under 5 y in sub-Saharan Africa (sSA), 
52% (1.2 million) in South Asia (SA), and 53% (107,000) 
in Latin America and the Caribbean (LA) (by UNICEF 
region) (1). Severe bacterial infections have been estimated 
to account directly for approximately one-third of neonatal 
deaths in these regions (2). An estimated three-quarters of a 
million deaths per year worldwide are attributed to neonatal 
severe  bacterial infection—more than child malaria deaths 
(0.6 million) and about four times those resulting from HIV 
in children (2).
Diagnosis of severe bacterial infection in neonates is 
 challenging in any setting. In resource-poor settings, where 
expertise and infrastructure are limited, diagnosis depends 
on simplified diagnostic algorithms with a focus on sensitivity 
rather than specificity, to allow early empiric antibiotic treat-
ment of neonates with possible severe bacterial infection (pSBI) 
to prevent neonatal deaths. However, the burden of severe bac-
terial infection in neonates is not limited to mortality, and for 
those neonates who are treated and survive, the consequences 
of neonatal infection (defined in Table 1) may be long-term 
neurodevelopmental impairment (NDI) and disability, with 
excess mortality after the neonatal period (Figure 1). Little 
attention has been paid to the long-term morbidity associated 
with neonatal infections, particularly in resource-poor settings 
(3). In resource-rich settings, contemporary work focuses on 
the strong association of infection in extremely low-birth-
weight and preterm neonates and NDI, and there has been 
surprisingly little recent work addressing long-term outcomes 
after severe bacterial infections, in term or moderately preterm 
neonates (4).
Describing the burden of impairment after severe bacterial 
infection in neonates is an essential step to support rational 
individual care and public health policy. The Global Burden 
of Disease (GBD) exercise estimated impairment outcomes in 
2010 for major neonatal conditions, including preterm birth, 
intrapartum-related neonatal encephalopathy, and neonatal 
infection (5). However, there were limitations to the GBD 
estimates; incidence of neonatal sepsis was back calculated 
from the estimated number of neonatal sepsis deaths using 
case fatality risks (CFRs); years lived with disability were 
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determined from the acute period of neonatal infection only 
(1 wk), and impairment after neonatal meningitis and teta-
nus were modeled using risk after infection in children of all 
ages. Estimates of impairment after meningitis were based on 
a recent systematic review, which excluded studies focusing on 
neonates (6). Outcomes for neonatal meningitis are likely to be 
different from outcomes after childhood meningitis due to dif-
ferences in etiology and the effect on the developing brain. The 
review reported moderate to severe impairment in 12.8% and 
mild impairment in 8.6% of survivors of childhood meningitis; 
for survivors of neonatal meningitis, impairment is likely to be 
higher (6).
table 1. Definitions for bacterial infection in neonates (see article 1 for further details) 
  Brief definition/explanation ICD10 codes
pSBI As defined by the WHO Young Infant Study 2: P35–P39
Any one of the following: a history of difficulty feeding, history of convulsions, movement 
only when stimulated, respiratory rate of 60 breaths per min or more, severe chest indrawing, 
temperature >37.5 °C or <35.5 °C (9)
Stillbirth Fetal death after 22 wk of completed gestation, or after 28 wk (or 1,000 g) for international 
estimates and comparison
P95
Infectious syndromes
 Neonatal sepsis Clinical signs of pSBI infection, with a blood culture positive for a pathogenic organism P36.0–36.9
 Neonatal meningitis Clinical signs of pSBI infection with a CSF culture positive for a pathogenic organism or a raised 
leukocyte count >50 × 106/sl in CSF (67)
G00.0–G00.9
 Neonatal pneumonia Clinical signs of pneumonia (fast breathing, indrawing) and informed by CXR (WHO criteria for 
end point pneumonia (68)
P23.0–P 23.9
 Neonatal tetanus All three of the following: (i) normal feeding and crying for the first 2 days of life; (ii) onset of 
illness between 3 and 28 days of life; and (iii) inability to suck (trismus), followed by stiffness 
(generalized muscle rigidity) and/or convulsions (muscle spasms) (69)
A33
Long-term complications in survivors of meningitis or tetanus
  Cognitive 
impairment
See introduction in this supplement for further details (8) F70–F79, F80.0, F81.0, F81.2, 
F81.8, F81.9, F06.7
 Motor impairment G80, G81.1, G82.1, G83.0–G83.3, 
G24.9, G25.3, G25.5, G25.9, F82, 
R26–R27
 Hearing impairment H90.3–H90.7
 Visual impairment H47, H48–H51, H53.0, H53.2, 
H53.4, H54.4–H54.7
CSF, cerebrospinal fluid; ICD10, International Classification of Diseases, 10th Revision; pSBI, possible severe bacterial infection; WhO, World health Organization.
Figure 1. Disease schema for severe bacterial infection in neonates.
Pregnancy
Stillbirth Death Death
Impacts on
physical
health
Neurological,
neurodevelopmental,
and hearing
Impacts on
mental health
Normal
development
Tetanus
Pneumonia
Sepsis
Meningitis
Possible
severe
bacterial
infection
Exposure
to infection
Uncomplicated
Im
pa
irm
e
n
t
In
cr
ea
se
d 
ris
k 
fo
r
th
os
e 
bo
rn
 p
re
te
rm
Neonatal period Childhood and adulthood
74 Pediatric ReSeARCh     Volume 74  |  Number s1  |  December 2013  Copyright © 2013 International Pediatric Research Foundation, Inc.
Beyond survival: neonatal infections         Articles
In this article, we present systematic reviews, meta-analyses, 
and the first regional estimates of impairment after neonatal 
meningitis and neonatal tetanus in SA, sSA, and LA, regions 
with high disease burden (7). We also discuss the program-
matic implications and important data gaps.
Methods
This article is part of a supplement including estimates for four other 
neonatal conditions. The general methods are described elsewhere 
(8). Here, we detail specific methods for estimates of impairment after 
neonatal infections.
Definitions
Case definitions of pSBI and specific diagnoses of neonatal sepsis, 
meningitis, pneumonia, and tetanus are given in Table 1. The defi-
nition of pSBI is based on the most recent WHO multisite study of 
severe illness in young infants. This study reported that the presence 
of any one of the seven clinical signs and symptoms predicted severe 
illness requiring hospitalization in neonates aged 0–7 days, using phy-
sician judgment as gold standard, with a sensitivity of 85% and speci-
ficity of 75% (9). For sepsis, meningitis, and pneumonia, the primary 
clinical diagnosis, based on physician judgment and microbiological 
testing, was used, as far as possible according to the criteria in Table 1.
NDI was classified as moderate/severe (cognitive and/or motor 
and/or vision and/or hearing impairment) and mild (cognitive and/
or motor and/or vision and/or hearing impairment). Detailed defini-
tions within these criteria and comparison with GBD definitions are 
presented elsewhere (8).
sSA includes GBD regions sSA central, sSA east, sSA west, and sSA 
southern. SA includes GBD regions Asia south and Asia southeast. 
LA includes GBD regions LA central, LA Andean, LA southern, LA 
tropical, and the Caribbean (7).
Data Searches and Inputs
Systematic literature reviews were undertaken for each of the esti-
mation parameters required by applying the general search strategy 
described elsewhere (8). Parameters required were as follows: inci-
dence of pSBI, proportions of pSBI cases by specific infection diag-
nosis (sepsis, meningitis, or pneumonia), neonatal CFRs specific to 
each infectious clinical diagnosis (sepsis, meningitis, pneumonia, and 
tetanus), and proportions of survivors with long-term impairment 
outcomes.
Search terms used included multiple variants of terms cover-
ing the following areas “meningitis” or “sepsis” or “tetanus” or 
“pneumonia” or “infection” and “newborn/infant” and “outcome/
impairment” and used medical subject headings (MeSH) terms 
when available (see Supplementary Information online section I 
for full details of search terms). Snowball searching was used to 
identify further studies of interest by screening the reference lists 
of retrieved studies.
Inclusion criteria were as follows: for incidence of pSBI, we 
included recent (median data collection year 2000 or later) studies, 
with a population denominator and diagnosis of pSBI consistent with 
our case definition. For searches to apportion specific diagnoses (sep-
sis, meningitis, and pneumonia), we only included studies focusing 
on neonates with pSBI diagnosis based on the seven clinical signs 
and symptoms indicative of pSBI in the second WHO young infant 
study (9). For neonatal CFRs, we included studies reporting deaths 
associated with infection, based as far as possible on our case defini-
tions (Table 1), from low-income countries from 1980 onwards. For 
impairment outcomes after severe neonatal bacterial infection, to 
maximize the data available, we included studies worldwide report-
ing impairment outcomes after specific neonatal infection diagnoses, 
based as far as possible on our case definitions, from 1964 (the start 
of a computerized database of medical literature by the US National 
Library of Medicine) to February 2013. Exclusion criteria were as fol-
lows: we excluded studies focusing mostly on very preterm neonates 
(<32 wk gestation or <1,500 g) from our analyses because they are 
included in estimates of impairment following preterm birth in this 
supplement (10).
Modeling Approach for Impairment After Severe Bacterial 
Infection in Neonates
A three-step model to estimate impairment specific to neonatal sepsis, 
meningitis, and pneumonia was developed (Figure 2), similar to the 
generic model described elsewhere (8). We calculated a quantitative 
assessment of the uncertainty surrounding these estimates using a 
statistical approach based on the compartmental model, taking 1,000 
random draws at each step, assuming a normal distribution with 
mean equal to the point estimate of the parameter and SD equal to the 
estimated standard error of the parameter. We summed the data at the 
worldwide or regional level for each draw and present the 2.5th and 
97.5th centiles of the resulting distributions as the uncertainty range.
Compartmental Model Steps 1–3
A compartmental model was constructed to estimate steps 1–3. In 
step 1, estimated incidence of pSBI in neonates >32 wk gestation (or 
>1,500 g) (Seale et al., unpublished data) was used to estimate the 
 proportion of neonates with pSBI who would be diagnosed with a 
specific clinical infection syndrome, e.g., meningitis, pneumonia, 
or sepsis (Figure 2). In step 2, to calculate the number of survivors 
among those estimated to seek care, CFRs were estimated based on 
facility data (using a pooled estimate). For those cases who did not 
seek care, high CFRs were assumed (95%). To estimate the number 
of impaired survivors (step 3), we used the estimated number of sur-
vivors from step 2 and pooled estimates of the risk of impairment 
associated with particular clinical infection syndromes.
For cases of neonatal meningitis, we undertook a sensitivity analy-
sis, using facility-based data to estimate incidence risk of neonatal 
meningitis where the number of facility live births was the denomina-
tor. We applied this incidence risk, adjusting for care seeking, to live 
births in 2010 to provide an alternative estimate of total meningitis 
cases in 2010.
Modeling Approach for Impairment After Neonatal Tetanus
Estimation of cases of neonatal tetanus was restricted by the lim-
ited availability of incidence data and the lack of concurrent teta-
nus toxoid vaccination data, especially given the recent scale up 
to high coverage of this vaccination in women of reproductive age 
(11,12). Given the lack of reliable incidence data, we back calcu-
lated the incidence of tetanus from the estimated number of deaths, 
using estimated CFRs for neonatal tetanus (see Supplementary 
Information online for pooled estimate of CFR). This approach has 
limitations, but as the numbers of deaths and cases are relatively 
small at the global level, it has less of an impact than using this 
approach for a more common condition such as neonatal sepsis. 
This process included an adjustment for estimates of neonatal teta-
nus deaths to apply them to the GBD regions used here because the 
published estimates of neonatal tetanus deaths apply to slightly dif-
ferent WHO-defined regions (2).
Estimation of DALYs
DALYs are calculated as the sum of years of life lost due to mortality 
and years lived with disability (prevalence of a condition × disability 
weight).
Estimation of DALYs and years lived with disability associated with 
neonatal meningitis, sepsis, pneumonia, and tetanus, as undertaken 
in estimates described elsewhere in this supplement (8), and in line 
with GBD estimates, were not completed for this study due to limita-
tions in parameters and estimates, as described in the discussion.
results
Input Parameters and Estimation Outputs
The steps of the compartmental model (Figure 2) were applied 
in sequence for the number of live births (>32 wk gestation or 
>1,500 g) in SA, sSA, and LA for the year 2010. The param-
eters and calculations at each step are detailed with a short 
summary of the results. A summary of the parameter inputs 
are shown in Table 2 and detailed in the Supplementary 
Information online.
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Step 1: Incidence of Specific Infection Diagnoses
Incidence of pSBI. Incidence of pSBI was determined from 
a meta-analysis, as described elsewhere (Seale et al., unpub-
lished data). There were an estimated 7.6 pSBI cases per 100 
live births (95% confidence interval (CI): 6.1–9.2) and a con-
sistently higher risk for male babies (risk ratio 1.12 (95% CI: 
1.06–1.08)) (Seale et al., unpublished data). This estimate does 
not take into account the estimated sensitivity of pSBI diag-
nosis (85%) (9). We were unable to include sex differences in 
further steps of the model due to the paucity of data by sex on 
specific diagnoses.
Proportion of pSBI cases with diagnosis of neonatal meningi-
tis, sepsis, or pneumonia. To apportion the envelope of pSBI 
cases to infection syndromes (meningitis, sepsis, or pneumo-
nia), site-specific data from the second multicountry WHO 
Young Infant Study of Neonatal Sepsis (9) were used (Bolivia 
(13), Ghana (14), India (15,16), and South Africa (17). Meta-
analyses (see Supplementary Information online) resulted 
in the following estimates: neonatal sepsis accounted for 25% 
(95% CI: 16–34%) of pSBI cases, five data sets, N = 532; neo-
natal meningitis accounted for 3% (95% CI: 0.3–6%), two data 
sets, N = 217; and neonatal pneumonia accounted for 8% (95% 
CI: 2–13%), five data sets, N = 532 (Table 2). Estimated num-
bers of cases of neonatal sepsis, meningitis, and pneumonia by 
region are shown in Figure 3.
The sensitivity analysis of incidence of neonatal menin-
gitis estimated from facility-based data was based on eight 
data sets (see Supplementary Information online). Based 
on these data, we estimated one case (95% CI: 1–2) of neo-
natal meningitis per 1,000 live births, and after adjusting 
for care seeking, we estimated 150,000 (uncertainty range: 
78,000–230,000) cases of neonatal meningitis in SA, sSA, and 
LA. This is comparable with our estimate based on pSBI and 
proportionate split of neonatal meningitis at 200,000 cases 
(21,000–350,000), although both estimates have considerable 
uncertainty.
Estimate of cases of neonatal tetanus. Cases of neonatal tetanus 
were estimated based on estimated tetanus deaths by WHO 
region (2) adjusted for GBD regions defined here, and back 
calculated using the pooled estimate of CFR given in step 2.
Estimates of neonatal sepsis, meningitis, pneumonia, and 
tetanus. We estimated 6.8 million (uncertainty range: 5.4–8.1 
million) cases of pSBI in 2010 in neonates >32 wk gestation 
(or >1,500 g), which included 1.7 million (1.1– 2.4 million) 
cases of neonatal sepsis, 200,000 cases (21,000–350,000) of 
neonatal meningitis, and 510,000 cases (150,000–930,000) of 
neonatal pneumonia. There were an estimated 79,000 cases 
(70,000–91,000) of neonatal tetanus. These are given by region 
in Table 3.
Figure 2. Parameters required and three-step modeling process for the estimation of the burden of neonatal infection. HIC, high-income country; pSBI, 
possible severe bacterial infection.
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Step 2: Calculation of the Number of Postneonatal Survivors
CFRs for neonatal meningitis, neonatal sepsis, neonatal 
pneumonia, and neonatal tetanus in those who seek care. 
CFR estimates for neonatal sepsis were obtained from 7 
data sets with 1,268 cases, for neonatal meningitis from 
21 data sets with 1,642 cases, and for neonatal pneumo-
nia from 2 data sets with 534 cases. For neonatal tetanus, 
they were obtained from 5 data sets with 1,448 cases and 
from searches included and used in the GBD estimates (18). 
Estimated CFRs (Table  2) were as follows: neonatal sep-
sis 18% (95% CI: 11–25%), neonatal meningitis 36% (95% 
CI: 30–42%), neonatal pneumonia 11% (95% CI: 4–17%), 
and neonatal tetanus 64% (95% CI: 55–72%) (18). Details 
of the meta-analyses are included in the Supplementary 
Information online.
Coverage and quality of care. Data on care-seeking behaviors in 
low- and middle-income countries were recently assessed and 
reported in a systematic review (19). We were unable to iden-
tify any further data. The published median (59% seek care) was 
used in our model for all regions (19). We did not calculate esti-
mates of uncertainty around deaths in those who did not seek 
care using this median value, with a large range in the data inputs 
(10–100%). We estimated that 95% of cases of neonatal sepsis, 
meningitis, or pneumonia would die if they did not seek care, so 
only a small proportion (5%) of meningitis survivors who did not 
seek care are included in impairment estimates (step 3).
table 2. Summary of input data for estimation parameters in terms of incidence, case fatality rates, and impairment risk for survivors for SA, sSA, 
and LA
No. of live births in 2010 
in SA, sSA, and LA (>32 wk 
gestation) 89,000,000
ST
EP
 1
pSBI incidence Pooled estimate: 7.6 of 100 live births (95% CI: 6.1–9.2) (Seale et al., unpublished 
data)
N/A
Neonatal sepsis Neonatal 
pneumonia
Neonatal meningitis Neonatal tetanus
ST
EP
 2
% pSBI cases diagnosed 
with infection syndrome 
(95% CI)
24.8 (15.8–33.8) 7.5 (2.2–12.8) 2.9 (0.3–5.6) N/A
Cases (uncertainty) 1,700,000  
(1,100,000–2,400,000)
510,000  
(150,000–930,000)
200,000  
(21,000–350,000)
80,000  
(70,000–91,000)
Care seeking 59% (20)
CFR with care
Countries 6 2 12 14
Data sets 7 2 21 5
N 4,369 534 1,461 1,448
Data range (%) 7–36 8–14 12–67 37–83
Pooled estimate (%) 18 11 36 64
(95% CI) (11–25) (4–17) (30–42) (55–72)
ST
EP
 3
Moderate/severe NDI Unable to estimate
Countries 6 4
Data sets 8 4
N 451 89
Data range (%) 15–38 10–44
Pooled estimate/100 live 
births (%)
23 16
(95% CI) (19–26) (6–27)
Mild NDI Unable to estimate Unable to estimate
Countries 4
Data sets 5
N 311
Data range (%) 5–36
Pooled estimate/100 live 
births (%)
12
(95% CI) (5–19)
CFR, case fatality risk; CI, confidence interval; LA, Latin America, N/A, not applicable; NDI, neurodevelopmental impairment; pSBI, possible severe bacterial infection; SA, South Asia; sSA, 
sub-Saharan Africa.
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Hence in SA, sSA, and LA, applying the above CFRs to the 
incidence estimates, in those who seek care, there were 140,000 
deaths (uncertainty range: 90,000–300,000) from neonatal 
sepsis, 42,000 (5,000–97,000) deaths from neonatal meningi-
tis, and 42,000 (6,000–68,000) deaths from neonatal pneumo-
nia in neonates >32 wk gestation (or >1,500 g). In those who 
did not seek care, we estimated 650,000 deaths from neonatal 
sepsis, 76,000 deaths from neonatal meningitis, and 200,000 
deaths from neonatal pneumonia in neonates >32 wk gestation 
(or >1,500 g). In total, therefore, with this CFR method, we 
estimated 800,000 deaths from neonatal sepsis, 120,000 from 
neonatal meningitis, and 240,000 from neonatal pneumonia, 
totaling just more than 1.0 million deaths in neonates >32 wk 
gestation (or >1,500 g).
Estimates of the number of postneonatal survivors. Of those 
who sought care, we estimated 840,000 survivors (510,000–1.2 
million) of neonatal sepsis, 74,000 (8,600–150,000) survivors 
of neonatal meningitis, and 260,000 (80,000–490,000) survi-
vors of neonatal pneumonia. Of those who did not seek care, 
we estimated only 34,000 survivors of neonatal sepsis, 4,000 
survivors of neonatal meningitis, and 10,000 survivors of neo-
natal pneumonia.
In total, we estimated 880,000 survivors (540,000–1.2 mil-
lion) of neonatal sepsis, 78,000 survivors (11,000–150,000) of 
neonatal meningitis, and 270,000 survivors (89,000–500,000) 
of neonatal pneumonia.
We applied estimates from previously published work (2) to 
GBD regions defined here, estimating a total of 50,000 neonatal 
Figure 3. Estimated cases, with uncertainty of neonatal sepsis, meningitis, pneumonia, and tetanus in South Asia, sub-Saharan Africa, and Latin America, 
respectively.
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table 3. Regional burden of neonatal infection and levels of impairment in survivors of neonatal meningitis and neonatal tetanus 
Neonatal meningitis Neonatal tetanus Neonatal sepsis Neonatal pneumonia
SA sSA LA SA sSA LA SA sSA LA SA sSA LA
Cases in 1,000s  
(95% CI)
100  
(13–210)
69  
(8–140)
21  
(2–40)
31  
(27–35)
45  
(40–52)
4  
(3–4)
900  
(580–1,300)
590  
(380–870)
180 (120–
270)
270  
(82–500)
180  
(54–
330)
55  
(17–
100)
Deathsa 63,000 42,000 13,000 19,000 28,000 2,400 440,000 270,000 83,000 120,000 89,000 27,000
Survivors with 
moderate to severe 
impairment (95% CI)
9,500  
(1,400–
19,000)
6,300  
(950–
12,000)
1,900  
(300–
3,800)
1,800  
(650–
3,400)
2,700  
(950–
5,000)
230  
(80–
430)
Unable to estimate due to data gaps
Survivors with mild 
impairment (95% CI)
4,900  
(1,100–
25,000)
3,200  
(330–
7,400)
1,000  
(220–
5,200)
Unable to estimate
GBD2010 estimated 
DALYs in 1,000s  
(95% CI)b
20,000c  
(12,000–
34,000)
19,000  
(11,000–
30,000)
1,600  
(970–
2,600)
CI, confidence interval; DALY, disability-adjusted life year; GBD, Global Burden of Disease; LA, Latin America, N/A, not applicable; NDI, neurodevelopmental impairment; pSBI, possible 
severe bacterial infection; SA, South Asia; sSA, sub-Saharan Africa.
aUncertainties not included in estimates of death, which should be interpreted with caution, as discussed further in the text. bGBD region South Asia only (does not include Southeast 
Asia as in our definition). cAs reported in GBD2010, for sepsis and other infections of the newborn baby. Based on years lived with disability and then years of life lost from acute 
infection episode assumed to last for 1 wk, with sequelae after meningitis based on review of childhood (postneonatal) meningitis. 
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tetanus deaths. Of these, there were an estimated 29,000 sur-
vivors (20,000–41,000). Estimates by region are presented in 
Table 3.
Step 3: Calculation of the Number of Impaired Survivors
Impairment risk. There are very few data on impairment risk 
in survivors of neonatal bacterial infections. Estimates of 
impairment following neonatal meningitis were mainly iden-
tified from studies in high-income settings. We used eight 
studies, which included 451 survivors of neonatal meningi-
tis and estimated that 23% (95% CI: 19–26%) were moder-
ately to severely impaired (Figure 4). For mild impairment, 
we used five studies (311 survivors), resulting in an estimate 
of 12% (95% CI: 5–19%). Specifically for hearing impair-
ment, we identified 11 studies (442 survivors), resulting in an 
estimate of 7% (95% CI: 3–12%); these cases were included 
in the combined categories of impairment; for details, see 
Supplementary Information online.
Estimates of impairment after neonatal tetanus came from 
4 studies with 89 survivors, of whom 16% (95% CI: 6–27%) 
had moderate to severe impairment (Figure 5). Data were 
even more limited for mild impairment after neonatal tetanus, 
with widely differing estimates. One study reported 2 of 43 
survivors with mild impairment, reviewed 6 mo to 4 y after 
recovery (20) and another identified 5 of 10 survivors (50%) 
with mild impairment (21). There was one further study from 
Kenya, which reported 33 neonatal survivors, 2 of whom died 
after the neonatal period and 10 of whom moved away (22). 
One of those who died had a history compatible with severe 
NDI, but none of those who were able to be followed up had 
Figure 4. Meta-analysis of eight studies (N = 451) reporting the incidence of any moderate/severe impairment (motor, cognitive, hearing, or vision) 
outcomes after neonatal meningitis. CI, confidence interval; ES, estimate.
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Figure 5. Meta-analysis of four studies (N = 89) reporting the incidence of any moderate/severe impairment (motor, cognitive, hearing, or vision) out-
comes after neonatal tetanus. CI, confidence interval; ES, estimate.
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moderate to severe impairment, and data on mild impairment 
outcomes were not comparable with our definitions and thus 
not included in the meta-analysis.
We were unable to identify sufficient data on impairment 
after neonatal sepsis and neonatal pneumonia to estimate the 
burden from these severe bacterial infections.
Estimates of the number of impaired survivors of neonatal 
meningitis and neonatal tetanus. After neonatal meningitis (in 
neonates >32 wk gestation (or >1,500 g)) in 2010, there were 
an estimated 18,000 (uncertainty range: 2,700–35,000) moder-
ately to severely impaired survivors and 9,200 (2,000–47,000) 
mildly impaired survivors. Of those with impairment, 5,600 
(1,200–29,000) survivors had hearing impairment. After neo-
natal tetanus infection, there were an estimated 4,700 (1,700–
8,900) neonatal survivors with moderate to severe impairment. 
Estimates by region are presented in Table 3.
discussion
The estimated 6.7 million (uncertainty range: 5.4–8.1 mil-
lion) cases of pSBI per year in neonates >32 wk gestation (or 
>1,500 g) are associated with a major burden on the health sys-
tem and on health workers, with a need for antibiotic therapy, 
even though many do not have a final diagnosis of invasive 
bacterial infection (Seale et al., unpublished data). Our esti-
mates of cases of true invasive bacterial disease are lower but 
still indicate a major burden from neonatal sepsis, meningitis, 
and pneumonia in SA, sSA, and LA. These are the first esti-
mates of severe bacterial infections derived from the estimated 
incidence of pSBI and align with recent estimates of severe 
pneumonia in young children, which suggested 3 million cases 
worldwide (23). Although no separate estimates of neonatal 
infections were provided in the pneumonia study, the inci-
dence risk of admission for “severe pneumonia” (defined using 
WHO case criteria) was noted to be three times higher for neo-
nates compared with that for all infants (0–59 mo). The burden 
of neonatal infections in non-preterm babies in SA, sSA, and 
LA is very high compared with that in babies in resource-rich 
regions, where the numbers of sepsis and neonatal meningitis 
cases are much lower but still constitute a considerable burden 
of disease (24).
There are limitations to these estimates and considerable 
uncertainty, particularly in apportioning of pSBI to the three 
infection syndromes (sepsis, pneumonia, and meningitis), 
because this split is based on just one multicountry study (9), 
with only two studies reporting meningitis outcomes. The 
young infant algorithm, which is also only 85% sensitive for 
pSBI, was based on those admissions, and admissions included 
other diagnoses such as hyperbilirubinemia, diarrhea, neo-
natal encephalopathy, and, in some cases, preterm birth (9). 
However, the estimate of neonatal meningitis cases using facil-
ity-based data, and adjusting for care seeking, was comparable 
with that based on apportioning of the incidence of pSBI. The 
estimates for each region are based on the number of live births 
in 2010 (>32 wk gestation or >1,500 g) and on application of 
the same parameters to each region. The data did not allow 
region-specific incidence risks and so may be missing impor-
tant regional differences in pSBI incidence and in proportions 
of neonatal sepsis, meningitis, and pneumonia, in addition to 
missing differing care-seeking behavior, treatment rates, and 
subsequent outcomes.
The mortality burden from severe bacterial infection in 
neonates is well recognized (25). However, the total neonatal 
deaths estimated herein (1.2 million) exceed those presented by 
the Child Health Epidemiology Reference Group, which total 
400,000 neonatal deaths due to pneumonia and sepsis/menin-
gitis in sSA and SA and 720,000 worldwide (1,2). The Institute 
for Health Metrics Evaluation gives a similar total of 750,000 
for neonatal infection deaths (26). The methods used by both 
the Child Health Epidemiology Reference Group (2) and the 
Institute for Health Metrics Evaluation (26) examine mortality 
data and assign a proportion of deaths to a specific cause are 
based on many more input data and are likely more robust. The 
estimates here may be higher because of assumptions in care-
seeking behavior (that 41% did not seek care, based on a pub-
lished meta-analysis (19)) and the high CFR (95%) applied to 
those with sepsis, meningitis, or pneumonia who did not seek 
care. The published estimate that 41% do not seek care is based 
on limited data (22 studies, 17 of which were from SA (19)) and 
was applied in our model for all regions. For those who do seek 
care, CFRs are well known to be problematic in burden estima-
tion work, because they are rarely population based, and tend to 
miss the mildest cases, resulting in an overestimate of mortal-
ity (27). Importantly, the Child Health Epidemiology Reference 
Group and the Institute for Health Metrics Evaluation estimates 
differ in the proportional split of deaths attributed to pneumo-
nia vs. sepsis/meningitis, with more deaths attributed to pneu-
monia in the Child Health Epidemiology Reference Group, 
underlining the greater uncertainty in attributed syndrome-
specific diagnoses based primarily on clinical symptoms that 
usually overlap in neonates.
The calculation of disability-adjusted life years (DALYs) 
requires estimates of survivors of the specific condition (e.g., 
neonatal sepsis), the excess mortality in postneonatal survi-
vors of the condition, and a disability weight for the condi-
tion. Neonatal survivors of meningitis, sepsis, pneumonia, 
and tetanus may have increased rates of mortality in infancy, 
childhood, and later adult life, associated with disability. Due 
to the limitations and uncertainty in our estimates of neonatal 
survivors and expected excess mortality, apart from the lack 
of disability weights for the specific neonatal infections in the 
recent GBD2010 estimates, DALYs were not able to be calcu-
lated here. The DALYs presented in Table 3 are therefore those 
published in the GBD2010 estimates (5).
Estimates for NDI are limited by lack of data on impairment 
after neonatal sepsis and neonatal pneumonia. However, the 
burden of NDI from neonatal meningitis is high, with a third 
of all survivors impaired (Figure 6). Our estimate of the risk 
of moderate to severe NDI (23%; 95% CI: 19–26%) is higher 
than the previously published estimate of NDI after child-
hood meningitis (12.8%; 95% CI: 7.2–21.1%) (6). This is to be 
expected because etiology varies with age and infection during 
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brain development increases the likelihood of NDI after neo-
natal meningitis, compared with the same for childhood 
meningitis. Although the risk of impairment from neonatal 
infection is strongly associated with decreasing gestational age, 
impairment outcomes after Group B Streptococcus meningitis 
still show a high (19%) burden of severe impairment in term 
infants in resource-rich countries in a recent study (1998–
2006) from two hospitals in the United States (28).
In terms of neonatal tetanus, although our estimate of 4,700 
cases (uncertainty range: 1,700–8,900) of moderate to severe 
NDI is a comparatively small number, and progress has been 
made in reducing neonatal tetanus incidence, it must be 
remembered that this is an entirely preventable disease. In this 
case, therefore, the challenge is to improve prevention, through 
immunization, to prevent all these cases (11).
Data Gaps and Improving the Data
The data here follow the “inverse care law,” with the heaviest 
burden areas having the least data (summarized in Table 4) 
(25). NDI data after neonatal sepsis and neonatal pneumonia 
are lacking, in babies of >32 wk gestation (Table 4). We cannot, 
therefore, estimate NDI outcomes in the 880,000 (540,000 to 
1.2 million) survivors of neonatal sepsis and 270,000 (89,000–
500,000) survivors of pneumonia. With these data gaps for the 
more common severe bacterial infections, we are left “stum-
bling in the dark” (29).
From resource-poor settings, the only article identified 
on neurodevelopmental outcomes after neonatal sepsis was 
from Kenya, which followed up 24 infants previously admit-
ted with neonatal sepsis. It was reported that there were 
more motor difficulties in cases compared with commu-
nity controls, in particular 4 of 24 children were unable to 
stand at 18–32 mo (30). From resource-rich settings, there 
are historical data from Sweden, where neurodevelopmental 
outcomes after 320 cases of invasive neonatal bacterial infec-
tion are described. Of the 110 who survived neonatal sep-
sis, 20 had sequelae (5%) (31). Less direct, but more recent, 
evidence comes from a case–control study from the United 
States on the impact of maternal infection and inflamma-
tion on neonates of >32 wk gestation. Forty-six children 
with unexplained cerebral palsy were compared with term 
controls, and 22% of the cases were exposed to maternal 
infection compared with 2.9% of controls (odds ratio: 9.3; 
95% CI: 3.7–23.0) (32). This is supported by another study 
of antenatal and intrapartum risk factors for seizures in 
term newborns where maternal fever and infection were 
associated with increased risk (33). The ORACLE study, a 
multisite randomized controlled trial evaluating the use 
of co-amoxiclav and/or erythromycin on preterm rupture 
of membranes and spontaneous preterm labor, supports 
this finding. Seven-year follow-up data from this factorial 
trial indicated that the proportion of children with cerebral 
palsy born after 32 wk gestation was higher in the sponta-
neous preterm labor arm (73%) and the preterm rupture of 
membrane arm (30%) compared with that in the controls 
(34). There are more data in preterm neonates. In resource-
rich settings, brain imaging is used in high-risk neonates 
to detect white matter injury, which helps to predict likely 
impairment outcomes. In the United States, in a study of 
133 neonates (<34 wk gestation), 13% (6 infants) of infants 
Figure 6. Regional burden of neonates with meningitis showing mortality, impairment, and the proportion with impairment-free survival. Note that 
impairment outcomes following neonatal sepsis could not be estimated due to lack of data. Outcomes following neonatal tetanus are shown in table 2.
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who had any episode of sepsis had evidence of white matter 
injury compared with 4.7% (4 infants) who did not have a 
documented episode of postnatal sepsis (odds ratio: 3.2; 95% 
CI: 0.8–11.8) (35). This is supported by other studies, includ-
ing outcomes after late-onset sepsis (36), and a study from 
Sweden following up extremely preterm infants; sepsis was 
found to independently increase the risk of cerebral palsy 
(odds ratio: 3.23; 95% CI: 1.23–8.48) and NDI (odds ratio: 
1.69; 95% CI: 0.96–2.98) (37).
For neonatal meningitis, which accounts for the minority 
of severe bacterial infection cases, as illustrated in Figure 7, 
the available data go through a cascade of diminishing avail-
ability, from pSBI incidence, the split into various infection 
syndromes, CFRs, and NDI risk. Available published stud-
ies of NDI after neonatal meningitis are old (1970–1998) and 
from high-income countries, with the exception of two from 
Nigeria. For neonatal tetanus, data on NDI outcomes were 
only able to be included from four publications (1964–1981) 
from Europe and Asia.
These data gaps, and the lack of investment in this subject 
to date, are in contrast to the large, long-term cohorts follow-
ing up HIV-exposed and HIV-infected infants (38), actually a 
much rarer occurrence and now accounting for ~140,000 child 
deaths annually (2). Although data are limited, we suggest that 
there are sufficient data here to indicate that determining the 
impact of neonatal sepsis at all gestations on long-term impair-
ment is essential, particularly for low-resource settings where 
the burden is the highest.
Programmatic Implications
Despite the data limitations, it is clear that the burden attribut-
able to neonatal infections justifies greater strategic investment 
Figure 7. Summary of outcomes in terms of deaths and disability for neonates with sepsis, meningitis, or pneumonia born in South Asia, sub-Saharan 
Africa, and Latin America in 2010. aUncertainties not included in estimates of death, which should be interpreted with caution, and include adjustment for 
care-seeking behavior, as discussed in the text.
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table 4. Research in the context of the burden of neonatal infections 
Data findings: there is a large burden from neonatal infection
  For 2010, we estimated 1.7 million (1.1–2.4 million) cases of neonatal sepsis, 200,000 (21,000–350,000) cases of neonatal meningitis, 510,000 (150,000–
930,000) cases of neonatal pneumonia, and 79,000 (70,000 –91,000) cases of neonatal tetanus
  We were only able to estimate impairment for survivors of neonatal meningitis and neonatal tetanus. For neonatal meningitis, 23% (19–26%) of 
survivors had moderate to severe impairment (of which 7% (3–12%) had hearing impairment), and 12% (5–19%) were mildly impaired. An estimated 
16% (6–27%) of neonatal tetanus survivors had moderate to severe impairment
Data gaps and improvements: major gaps were found in the quantity and the quality of data to inform these estimates, including the following: 
 Geographic gaps especially for high-burden settings
 Inconsistent definitions for infection syndromes (sepsis, pneumonia, and meningitis) and impairment outcomes
  Virtually no follow-up studies of impairment after neonatal sepsis (excluding preterm babies). This is a substantial gap and a potentially large public 
health issue, given the high incidence in resource-poor settings
Data for action: programmatic priorities are clear, despite the data gaps, and include the following:
  Prevention of neonatal infections: this must be strategically addressed not only for facility births including preterm babies but also for 50 million home 
births
  Reduction of deaths and disability: immediate burden reduction is possible through increasing coverage and quality of case management of neonatal 
sepsis. To reach the poorest families, care must be brought closer to home, where appropriate, with introduction of community-based case management
 Identification and care of survivors with impairment to reduce disability from impairment and the impact on the child and their carer
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in prevention, improved case management, and better care of 
impaired survivors.
Prevention of neonatal infection is likely the most cost-effec-
tive intervention available not only for facility births and sick 
and preterm babies in hospitals but also for 50 million home 
births (39). Effective strategies to prevent severe neonatal infec-
tion in resource-poor settings are available. Clean delivery and 
chlorhexidine cord cleansing at and following delivery have 
been shown to reduce neonatal mortality in randomized con-
trolled trials in Pakistan and Bangladesh (40,41). Breastfeeding 
is important to initiate early (42) and is of low cost, yet it has 
received less global attention in recent years. Reducing expo-
sure to infection in high-risk groups (preterm and small- 
for-gestational-age neonates) through the use of Kangaroo 
Mother Care (43) is increasingly used in resource-rich neona-
tal intensive care units and in low-income settings to reduce 
mortality and infections, in addition to improving breastfeed-
ing, weight gain, and neurological outcomes (44). Emollients 
(aquaphor ointment or sunflower seed oil) decreased neonatal 
mortality by 28 and 32% in a randomized controlled trial in 
Bangladesh (45). In the longer term, maternal immunization 
may be an effective strategy to prevent neonatal sepsis, to be 
added to the existing program for neonatal tetanus.
Improved case management through better supportive care, 
along with effective antibiotic treatment regimens, would 
reduce mortality and morbidity (46). Increasing care coverage 
and bringing management closer to home through community 
outreach interventions, as shown in a trial of home-based care 
in India (47) and health facility care in Pakistan (48), to cover 
“hard to reach” sectors of the population, would help this. 
Trials are under way to evaluate simplified antibiotic therapy at 
home or first-level facilities in Bangladesh, Pakistan, and sev-
eral African countries, with results expected soon (49). There 
are few studies examining the effect of early treatment with 
oral antibiotics for local infections (skin, umbilicus, eye, and 
mouth) on the incidence of severe bacterial conditions.
Other case management strategies, important and applica-
ble to both resource-poor and resource-rich settings, include 
infection control, targeted antibiotic policies, and strict 
antibiotic stewardship. Increasing antibiotic resistance and 
hospital-acquired infection is a concern worldwide (50,51). 
Participation in infection surveillance networks has reduced 
hospital-acquired infections in resource-rich settings (52), 
together with bundles of care to reduce infections associated 
with central venous access (53,54). A number of other interven-
tions aimed at reducing morbidity and mortality from hospi-
tal-acquired sepsis in resource-rich regions have been studied 
with a focus on extremely preterm babies. Antifungal prophy-
laxis has shown benefit (55,56), but there are concerns about 
side effects and increased resistance, particularly in countries 
with lower incidence of Candida. Other strategies include use 
of oral bovine lactoferrin supplementation, which reduced the 
risk of late-onset sepsis in a single study (57); results of further 
studies are awaited. Several interventions, including intrave-
nous immunoglobulins, granulocyte colony-stimulating fac-
tor, granulocyte-macrophage colony-stimulating factor (58), 
and glutamine supplementation, have not proven effective 
(55,59).
Improving diagnostics would support improved case man-
agement in resource-poor settings, in addition to increasing 
knowledge of etiological agents to inform interventions, but 
data are limited (60). Innovation for diagnostics, especially 
point-of-care tests, for neonatal sepsis is challenging (61). 
Development of a rapid diagnostic test would represent a great 
advance, as seen for malaria diagnosis (62,63). Wider use of 
pulse oximetry may improve the specificity of diagnosis of 
severe illness but is yet to be tested in low-income settings (64).
Finally, more programmatic focus must be put on identifica-
tion and care of survivors with disability. Looking after a disabled 
child can place a high burden on both families (65) and the chil-
dren concerned. The children and families are stigmatized, and 
their educational and social opportunities are often limited.
Conclusion
Severe bacterial infection in neonates is a leading cause of neo-
natal mortality in low-income countries, despite affordable and 
feasible prevention and treatment interventions. Impairment 
in survivors likely represents a significant burden of disease 
that, to date, has not been fully counted or addressed.
SUPPLEMENTARY MATERIAL
Supplementary material is linked to the online version of the paper at 
http://www.nature.com/pr
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